How to balance the risk of missing a cancerous tumor with the risk of treating — at substantial human cost — when treatment may be unnecessary or futile? The new Canadian study of mammography, published Tuesday in BMJ, sharpens this question once again. Most of us who’ve been around a while know people, some […]